封面
市場調查報告書
商品編碼
1935182

注射給藥市場:按設備類型、材料類型、性別、給藥途徑、最終用戶和地區分類

Injectable Drug Delivery Market, By Device Type, By Material Type, By Usability, By Route of Administration, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2026 年,注射給藥市場規模將達到 6,500 億美元,到 2033 年將達到 9,000 億美元,2026 年至 2033 年的複合年成長率為 7%。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 6500億美元
歷史數據時期: 2020-2024 預測期: 2026-2033
預測期(2026-2033 年)複合年成長率: 7.00% 2033 年的預測值: 9000億美元

注射劑可將藥物直接輸送到作用部位,從而最大限度地提高生物利用度並避免首過效應。注射劑主要用於口服困難或穩定性較差的藥物。對於意識不清的患者或口服藥片和膠囊依從性差的患者,注射給藥可能是合適的選擇。

市場動態

糖尿病、心臟病和過敏性休克等慢性疾病的日益普遍推動了全球注射給藥市場的成長。根據《過敏、氣喘與臨床免疫學雜誌》報道,截至2015年,英國約有1,500萬人患有食物過敏。同樣,歐洲過敏與臨床免疫學會(EAACI)報告稱,截至2015年,英國約有1700萬人患有食物過敏,其中約350萬為兒童。日益增強的安全意識和對針刺傷的擔憂是推動注射給藥市場成長的關鍵因素。例如,世界衛生組織建議使用具有銳器損傷預防(SIP)功能的安全注射器來預防針扎傷。同樣,2017年5月,Innovative Neurons LLC宣布其名為FAST(快速、便利、安全且技術先進)的取得專利的自動伸縮多針注射器實現商業化,旨在減少針刺傷。眾多市場相關人員正致力於該領域的研發與進步。例如,輝瑞公司推出的ACT-O-VIAL系統是一種雙組分管瓶系統,只需按壓塑膠蓋即可復溶無菌注射劑。市場參與者推出的以患者為中心的設施預計將推動市場成長。例如,2018年7月,輝瑞宣布將在美國密西根州建造一座無菌注射劑生產設施。

然而,在預測期內限制市場發展的主要因素將是製造商的產品召回。例如,2018年4月,貝克頓·迪克森公司宣布召回其PosiFlush肝素封管沖洗注射器和預填充生理食鹽水注射器,原因是這些產品受到黏質沙雷氏菌的污染。

本次調查的主要特點

  • 本報告對注射藥物輸送市場進行了詳細分析,以 2017 年為基準年,給出了預測期(2018-2026 年)內的市場規模和複合年成長率(%)。
  • 該報告重點介紹了各個細分市場的潛在商機,並為該市場說明了一個引人注目的投資提案矩陣。
  • 該研究還提供了有關市場促進因素、限制因素、機會、新產品發布或核准、市場趨勢、區域展望以及主要企業的競爭策略的重要見解。
  • 該研究根據公司概況、財務表現、產品系列、市場佔有率、分銷策略、關鍵發展、策略和未來計劃等參數,對全球注射藥物輸送市場的主要企業進行了分析。
  • 本報告的研究結果將使負責人和經營團隊能夠就未來的產品發布、技術升級、市場擴張和行銷策略做出明智的決策。
  • 這份全球注射藥物輸送市場報告的目標受群眾外包括該行業的各類相關人員,例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員將能夠透過用於分析全球注射藥物輸送市場的各種策略矩陣輕鬆做出決策。

目錄

第1章 研究目標與前提條件

  • 調查目的
  • 先決條件
  • 簡稱

第2章 市場概覽

  • 報告概述
    • 市場定義和範圍
  • 執行摘要

第3章:市場動態、監理及趨勢分析

  • 市場動態
  • 影響分析
  • 主要亮點
  • 法規環境
  • 產品上市及核准情況
  • PEST分析
  • 波特分析
  • 市場機遇
  • 法規環境
  • 重大進展
  • 產業趨勢

4. 2020-2033年全球注射給藥市場(依器材類型分類)

  • 預填充式注射器
  • 自動注射器
  • 筆型
  • 普通注射器
  • 墨水匣
  • 安瓿
  • 管瓶
  • 其他

5. 2020-2033年全球注射藥物傳輸市場(依材料類型分類)

  • 玻璃
  • 塑膠

6. 2020-2033年全球注射給藥市場(依使用者性別分類)

  • 一次性的
  • 可重複使用的

7. 2020-2033年全球注射給藥市場(依給藥途徑分類)

  • 靜脈
  • 肌肉內注射
  • 皮下

8. 2020-2033年全球注射藥物傳輸市場(依最終用戶分類)

  • 醫院
  • 診所
  • 門診手術中心
  • 居家醫療
  • 其他

9. 2020-2033年全球注射給藥市場(依地區分類)

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲國家
  • 歐洲
    • 德國
    • 英國
    • 西班牙
    • 法國
    • 義大利
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • ASEAN
    • 亞太其他地區
  • 中東
    • 海灣合作理事會國家
    • 以色列
    • 其他中東國家
  • 非洲
    • 南非
    • 北非
    • 中非

第10章 競爭格局

  • Becton, Dickinson and Company
  • Pfizer Inc.
  • Novo Nordisk A/S
  • Gerresheimer AG
  • Carl-Zeiss-Stiftung
  • Terumo Corporation
  • Vetter Pharma-Fertigung GmbH &Co. KG
  • SHL Group
  • Owen Mumford Limited
  • Injex Pharma GmbH

第11章 分析師建議

  • 機會
  • 分析師觀點
  • Coherent Opportunity Map

第12章 參考文獻與調查方法

  • 參考
  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI2768

Injectable Drug Delivery Market is estimated to be valued at USD 650 Bn in 2026 and is expected to reach USD 900 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 650 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 7.00% 2033 Value Projection: USD 900 Bn

Injectables offer maximum bioavailability of drugs towards the intended site of action and avoid the first pass metabolism. The injectable route is mostly preferred for the drugs which can't be taken orally or have some stability problems. Unconscious patients or patients having low compliance towards oral tablets or capsules can be preferred for the injectable drug delivery therapy.

Market Dynamics

Increasing prevalence of chronic diseases such as diabetes, cardiac diseases, and anaphylaxis has supported growth of global injectable drug delivery market. According to the Allergy, Asthma & Clinical Immunology, in 2015, around 15 million people suffered from food allergies in the U.K. Similarly, according to the European Academy of Allergy and Clinical Immunology (EAACI), in 2015, around 17 million people suffered from food allergies in the U.K., of which around 3.5 million were children. Increasing awareness regarding safety and concern of needlestick injuries is a major factor driving growth of the injectable drug delivery market. For instance, the WHO recommended the use of safety syringes with sharp injury protection (SIP), in order to prevent needlestick injuries. Similarly, in May 2017, Innovative Neurons LLC announced to commercialize its patented auto retractable multi-needle syringe known as FAST (fast, accessible, safe, and technology) to decrease needlestick injuries. Various market players are focusing on the development and advancement in this space. For instance, ACT-O-VIAL System offered by Pfizer Inc. is a dual-component vial system that allows reconstitution of sterile, injectable medications by pressing on the plastic cap. The facility launch by market players to cater requirements of patients is expected to drive the market growth. For instance, in July 2018, Pfizer, Inc. announced to build sterile injectable pharmaceutical production facilities in the Michigan, U.S.

However, product recalls by the manufacturers is the major factors restraining the market over the forecast period. For instance, in April 2018, Becton Dickson and Company announced a recall of PosiFlush Heaparin Lock Flush Syringe, and Prefilled normal saline syringe, owing to the contamination with Serratia marcescens bacterium.

Key features of the study

  • This report provides in-depth analysis of the injectables drug delivery market and provides market size (USD million) and compound annual growth rate (CAGR %) for the forecast period (2018 - 2026), considering 2017 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the global injectable drug delivery market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Becton, Dickinson and Company, Pfizer Inc., Novo Nordisk A/S, Gerresheimer AG, Carl-Zeiss-Stiftung, Terumo Corporation, Vetter Pharma-Fertigung GmbH & Co. KG, SHL Group, Owen Mumford Limited, Injex Pharma GmbH.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics.
  • The global injectables drug delivery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global injectable drug delivery market

Market Segmentation

  • Device Type Insights (Revenue, USD Bn, 2026 - 2033)
    • Prefilled Syringes
    • Auto Injectors
    • Pens
    • Conventional Syringes
    • Cartridges
    • Ampoules
    • Vials
    • Others
  • Material Type Insights (Revenue, USD Bn, 2026 - 2033)
    • Glass
    • Plastic
  • Usability Insights (Revenue, USD Bn, 2026 - 2033)
    • Disposable
    • Reusable
  • Route of Administration Insights (Revenue, USD Bn, 2026 - 2033)
    • Intravenous
    • Intramuscular
    • Subcutaneous
  • End User Insights (Revenue, USD Bn, 2026 - 2033)
    • Hospitals
    • Clinics
    • Ambulatory Surgical Centers
    • Home Care Settings
    • Others
  • Regional Insights (Revenue, USD Bn, 2026 - 2033)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
    • North Africa
    • Central Africa
    • South Africa
  • Key Players Insights
    • Becton, Dickinson and Company
    • Pfizer Inc.
    • Novo Nordisk A/S
    • Gerresheimer AG
    • Carl-Zeiss-Stiftung
    • Terumo Corporation
    • Vetter Pharma-Fertigung GmbH & Co. KG
    • SHL Group
    • Owen Mumford Limited
    • Injex Pharma GmbH

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Injectable Drug Delivery Market, By Device Type
    • Global Injectable Drug Delivery Market, By Material Type
    • Global Injectable Drug Delivery Market, By Usability
    • Global Injectable Drug Delivery Market, By Route of Administration
    • Global Injectable Drug Delivery Market, By End User
    • Global Injectable Drug Delivery Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Market Opportunities
  • Regulatory Scenario
  • Key Developments
  • Industry Trend

4. Global Injectable Drug Delivery Market, By Device Type, 2020-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Prefilled Syringes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
  • Auto Injectors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
  • Pens
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
  • Conventional Syringes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
  • Cartridges
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
  • Ampoules
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
  • Vials
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)

5. Global Injectable Drug Delivery Market, By Material Type, 2020-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Glass
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
  • Plastic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)

6. Global Injectable Drug Delivery Market, By Usability, 2020-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Disposable
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
  • Reusable
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)

7. Global Injectable Drug Delivery Market, By Route of Administration, 2020-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Intravenous
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
  • Intramuscular
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
  • Subcutaneous
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)

8. Global Injectable Drug Delivery Market, By End User, 2020-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
  • Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
  • Home Care Settings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)

9. Global Injectable Drug Delivery Market, By Region, 2020 - 2033, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2033, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Device Type, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Material Type, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Usability, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Device Type, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Material Type, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Usability, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Device Type, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Material Type, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Usability, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Device Type, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Material Type, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Usability, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Device Type, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Material Type, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Usability, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Device Type, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Material Type, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Usability, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

10. Competitive Landscape

  • Becton, Dickinson and Company
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Novo Nordisk A/S
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Gerresheimer AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Carl-Zeiss-Stiftung
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Terumo Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Vetter Pharma-Fertigung GmbH & Co. KG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • SHL Group
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Owen Mumford Limited
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Injex Pharma GmbH
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

11. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

12. References and Research Methodology

  • References
  • Research Methodology
  • About us